NO961204L - Triaryletylenderivater for anvendelse innen terapi - Google Patents
Triaryletylenderivater for anvendelse innen terapiInfo
- Publication number
- NO961204L NO961204L NO961204A NO961204A NO961204L NO 961204 L NO961204 L NO 961204L NO 961204 A NO961204 A NO 961204A NO 961204 A NO961204 A NO 961204A NO 961204 L NO961204 L NO 961204L
- Authority
- NO
- Norway
- Prior art keywords
- therapy
- derivatives
- agents
- triarylethylene
- triarylethylene derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/20—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12661493A | 1993-09-24 | 1993-09-24 | |
| US08/259,797 US5525633A (en) | 1993-09-24 | 1994-06-15 | Triaryl-ethylene derivatives |
| PCT/US1994/009314 WO1995008528A1 (en) | 1993-09-24 | 1994-08-19 | Triaryl-ethylene derivatives for use in therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO961204D0 NO961204D0 (no) | 1996-03-25 |
| NO961204L true NO961204L (no) | 1996-03-25 |
| NO306292B1 NO306292B1 (no) | 1999-10-18 |
Family
ID=26824862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO961204A NO306292B1 (no) | 1993-09-24 | 1996-03-25 | Triaryletylenderivater for anvendelse innen terapi |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5684004A (no) |
| EP (1) | EP0720597B1 (no) |
| JP (1) | JPH09503761A (no) |
| CN (1) | CN1131415A (no) |
| AT (1) | ATE165594T1 (no) |
| AU (1) | AU678535B2 (no) |
| CA (1) | CA2171728C (no) |
| DE (1) | DE69409961T2 (no) |
| DK (1) | DK0720597T3 (no) |
| ES (1) | ES2115975T3 (no) |
| FI (1) | FI961339A7 (no) |
| HU (1) | HUT75933A (no) |
| IL (1) | IL111018A0 (no) |
| NO (1) | NO306292B1 (no) |
| NZ (1) | NZ273433A (no) |
| PL (1) | PL177833B1 (no) |
| WO (1) | WO1995008528A1 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| CN102379684B (zh) | 2005-04-28 | 2014-11-19 | 普罗透斯数字保健公司 | 药物信息系统 |
| KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료 |
| EP2398500B1 (en) | 2009-02-20 | 2019-03-13 | 2-BBB Medicines B.V. | Glutathione-based drug delivery system |
| ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1099093A (en) * | 1965-09-03 | 1968-01-17 | Ici Ltd | Alkene derivatives |
| EP0002097B1 (en) * | 1977-08-22 | 1981-08-05 | Imperial Chemical Industries Plc | Triphenylalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
-
1994
- 1994-08-19 HU HU9600727A patent/HUT75933A/hu unknown
- 1994-08-19 PL PL94313594A patent/PL177833B1/pl unknown
- 1994-08-19 DK DK94927182T patent/DK0720597T3/da active
- 1994-08-19 EP EP94927182A patent/EP0720597B1/en not_active Expired - Lifetime
- 1994-08-19 JP JP7509757A patent/JPH09503761A/ja not_active Ceased
- 1994-08-19 FI FI961339A patent/FI961339A7/fi not_active IP Right Cessation
- 1994-08-19 AU AU76707/94A patent/AU678535B2/en not_active Ceased
- 1994-08-19 CN CN94193479A patent/CN1131415A/zh active Pending
- 1994-08-19 NZ NZ273433A patent/NZ273433A/en unknown
- 1994-08-19 AT AT94927182T patent/ATE165594T1/de not_active IP Right Cessation
- 1994-08-19 WO PCT/US1994/009314 patent/WO1995008528A1/en not_active Ceased
- 1994-08-19 DE DE69409961T patent/DE69409961T2/de not_active Expired - Fee Related
- 1994-08-19 ES ES94927182T patent/ES2115975T3/es not_active Expired - Lifetime
- 1994-08-19 CA CA002171728A patent/CA2171728C/en not_active Expired - Fee Related
- 1994-09-21 IL IL11101894A patent/IL111018A0/xx unknown
-
1995
- 1995-06-05 US US08/463,792 patent/US5684004A/en not_active Expired - Fee Related
-
1996
- 1996-03-25 NO NO961204A patent/NO306292B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL313594A1 (en) | 1996-07-08 |
| NO961204D0 (no) | 1996-03-25 |
| ES2115975T3 (es) | 1998-07-01 |
| US5684004A (en) | 1997-11-04 |
| DK0720597T3 (da) | 1998-10-07 |
| EP0720597B1 (en) | 1998-04-29 |
| NZ273433A (en) | 1997-11-24 |
| FI961339A0 (fi) | 1996-03-22 |
| CN1131415A (zh) | 1996-09-18 |
| DE69409961D1 (de) | 1998-06-04 |
| CA2171728A1 (en) | 1995-03-30 |
| NO306292B1 (no) | 1999-10-18 |
| WO1995008528A1 (en) | 1995-03-30 |
| JPH09503761A (ja) | 1997-04-15 |
| AU678535B2 (en) | 1997-05-29 |
| AU7670794A (en) | 1995-04-10 |
| PL177833B1 (pl) | 2000-01-31 |
| FI961339L (fi) | 1996-03-22 |
| CA2171728C (en) | 2001-11-13 |
| IL111018A0 (en) | 1994-11-28 |
| EP0720597A1 (en) | 1996-07-10 |
| DE69409961T2 (de) | 1998-09-10 |
| HUT75933A (en) | 1997-05-28 |
| FI961339A7 (fi) | 1996-03-22 |
| ATE165594T1 (de) | 1998-05-15 |
| HU9600727D0 (en) | 1996-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| PT935465E (pt) | Compostos novos de imidazole substituido | |
| MX9705296A (es) | Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia. | |
| DK1036058T3 (da) | Adamantanderivater | |
| DE69808130D1 (de) | Adamantan-derivate | |
| ID23374A (id) | Halogenopirimidin | |
| ATE247470T1 (de) | Neue substituierte imidazolverbindungen | |
| DK0711140T3 (da) | Antimykotisk opløsning til negle | |
| NO990405L (no) | Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler | |
| FI953497A7 (fi) | Spirosykloalkyylisubstituoidut atsetidinonit, jotka ovat käyttökelpoisia hypokolesteroleemisina aineina | |
| ATE167670T1 (de) | N-alkylthiopolyaminderivate als radioprotektive mittel | |
| MX9201681A (es) | 4,5-dihidro-1h-pirazol-1-carboxiamidas 3,4,n-sustituidas y su uso como inseticidas. | |
| EA199900362A1 (ru) | Новые соединения, полезные для использования в качестве нейрозащитных средств | |
| RU95101375A (ru) | Производные n-(3-аминопропил)-n-фенил-5,6,7,8-тетрагидронафталин-2-карбоксамида, их получение и применение в терапии | |
| MX9101958A (es) | Inhibidores de acat de urea de aminosulfonilo | |
| FI970448A7 (fi) | N-substituoituja 3-atsobisyklo(3.2.0)heptaanijohdannaisia,jotka ovat k äyttökelpoisia neuroleptisina aineina | |
| NO961204D0 (no) | Triaryletylenderivater for anvendelse innen terapi | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| BG101221A (bg) | N-заместени азабициклохептанови производни, приложими като невролептици | |
| ES2152315T3 (es) | Xamoneline tartrato. | |
| TR200103126T2 (tr) | Yapısal titremenin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri | |
| BR9611904A (pt) | Dioxidos de ditiazol | |
| ES1020705Y (es) | Maquina portatil perfeccionada multiuso. | |
| ES1024223Y (es) | Unidad hermetica de uso personal. | |
| BG102613A (en) | New substituted imidazoles |